Delivering healthy bacteria in a pill could help patients harboring out-of-balance microbial communities.
The search giant says patents are rubbish. Yet it’s accumulating more of them than ever.
A Boston startup wants to create precise genome-editing treatments that can address more types of disease than previous gene therapy methods.
Physicists have developed a technique that can tell which parts of the brain rely on analog signals and which rely on digital signals.
The U.S. government is concerned that some of 23andMe’s health assessments could mislead customers.
Researchers uncover new ties between genetics and skin cancer by mining patients’ medical records.
How does the ability to instantaneously reallocate physical resources change the way companies source materials, manage operations, and go to market?
High-throughput sequencing takes another step into the clinic with first regulatory approvals.
The world’s largest electronics retailer thinks stores are an asset in the fight with online retailers.
Three large clinical trials show little benefit to analyzing the genes of patients to find the right dose of blood thinners.